Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
Clinical trial NCT04408625 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04408625
- Sponsor
- Prevail Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2029-11-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.